OGN — Organon & Co.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1821825 ·
Last close
$13.73
Market Cap
$3.61B
52W High
$13.78
52W Low
$5.67
ADV30
2,900,947
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,558,000,000 | 847,000,000 | 323,000,000 | 108,000,000 | 13,178,000,000 | 1,132,000,000 | 12,172,000,000 |
| Mar 2026 | 1,460,000,000 | 783,000,000 | 266,000,000 | 146,000,000 | 12,996,000,000 | 1,116,000,000 | 12,093,000,000 |
| Dec 2025 | 1,507,000,000 | 741,000,000 | 217,000,000 | -205,000,000 | 12,867,000,000 | 574,000,000 | 12,115,000,000 |
| Sep 2025 | 1,602,000,000 | 857,000,000 | 358,000,000 | 160,000,000 | 13,552,000,000 | 672,000,000 | 12,646,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$737,000,000
Investing CF
$130,000,000
Financing CF
$-313,000,000
CapEx
$-303,000,000
Dividends Paid
$-18,000,000
Buybacks
—
EPS Diluted TTM
$0.77
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$1,352,000,000
Inventory
$1,351,000,000
Receivables
$1,492,000,000
ST Investments
—
EBIT TTM
$959,000,000
Pretax Income TTM
$491,000,000
Interest Exp TTM
$468,000,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,127,000,064
EBITDA
$1,564,000,000
Free Cash Flow
$490,750,016
Enterprise Value
$11,002,992,640
Total Cash
$1,132,000,000
Total Debt
$8,552,999,936
Shares Out
262,609,433
Trailing EPS
$0.78
Book Value
$3.83
ROE
24.0%
ROA
5.7%
Div Yield
0.59%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,216,000,000 | 1,226,000,000 | 187,000,000 | 12,867,000,000 | 12,115,000,000 | 752,000,000 | 700,000,000 |
| Dec 2024 | 6,403,000,000 | 1,486,000,000 | 864,000,000 | 13,101,000,000 | 12,629,000,000 | 472,000,000 | 939,000,000 |
| Dec 2023 | 6,263,000,000 | 1,327,000,000 | 1,023,000,000 | 12,058,000,000 | 12,128,000,000 | -70,000,000 | 799,000,000 |
| Dec 2022 | 6,174,000,000 | 1,705,000,000 | 917,000,000 | 10,955,000,000 | 11,847,000,000 | -892,000,000 | 858,000,000 |
TTM Snapshot
Revenues TTM
$6,263,000,000
NetIncome TTM
$803,000,000
OpCashFlow TTM
$0
Assets (Latest)
$13,101,000,000
Forward EPS
$3.62
Max Pain — expiry 2026-12-18
max pain strike: $10.00 · spot: $13.73 · call oi: 3,984 · put oi: 1,367
Expected Move to 2026-12-18:
±$0.45
(3.28%) —
implied range
$13.28 –
$14.18
· ATM straddle on $14.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | $3.63B | $75.08 | — |
| XENE | Xenon Pharmaceuticals Inc. | $3.58B | $36.94 | — |
| ACAD | ACADIA PHARMACEUTICALS INC | $3.56B | $20.68 | — |
| IDYA | IDEAYA Biosciences, Inc. | $3.54B | $36.69 | — |
| LEGN | Legend Biotech Corp | $3.72B | $19.11 | — |
News headlines (Yahoo Finance, 1h cache)
Why Organon (OGN) Is Getting Attention Today
2026-09-22 12:15 · Yahoo
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device
2026-09-22 03:24 · Yahoo
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
2026-09-16 12:30 · Yahoo
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
2026-09-01 11:18 · Yahoo
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive
2026-09-10 20:18 · Yahoo
Is Trending Stock Organon & Co. (OGN) a Buy Now?
2026-09-21 13:00 · Yahoo
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
2026-09-14 11:30 · Yahoo
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
2026-09-08 13:00 · Yahoo
Orogen Royalties Acquires Two Gold Projects in Southwest Utah
2026-09-02 12:00 · Yahoo
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
2026-08-27 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.